Generalization of a targeted library design protocol: Application to 5-HT7 receptor ligands

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 6, 2004, Pages 2207-2215

  Nordling, Erik ^a   Homan, Evert ^a  

^a BIOVITRUM AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CROSSLINKING; CRYSTAL STRUCTURE; ENZYMES; NETWORK PROTOCOLS; ORGANIC ACIDS; PHOTONS; POLYPEPTIDES; PROTEINS;

DRUG DISCOVERY; G-PROTEIN COUPLED RECEPTORS (GPCR); LIGANDS;

LIBRARIES;

SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; FACTUAL DATABASE; GENETICS; HUMAN; PHYLOGENY; PROTEIN CONFORMATION;

BINDING SITES; DATABASES, FACTUAL; HUMANS; MODELS, MOLECULAR; PHYLOGENY; PROTEIN CONFORMATION; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 10044266768     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci049822w     Document Type: Article

References (47)

1. Apweiler, R.; Bairoch, A.; Wu, C. H.; Barker, W. C.; Boeckmann, B. et al. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 2004, 32 Database issue, D115-119.
2. Palezewski, K.; Kumasaka, T.; Hori, T.; Behnke, C. A.; Motoshima, H. et al. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289, 739-745.
3. Luecke, H.; Schobert, B.; Lanyi, J. K.; Spudich, E. N.; Spudich, J. L. Crystal structure of sensory rhodopsin II at 2.4 angstroms: insights into color tuning and transducer interaction. Science 2001, 293, 1499-1503.
4. Christopoulos, A. Allosteric binding sites on cell-surface receptors: novel targets for drug discovery. Nat. Rev. Drug Discov. 2002, 1, 198-210.
5. Jacoby, E.; Fauchère, J. L.; Raimbaud, E.; Ollivier, E.; Michel, A. et al. A Three Binding Site Hypothesis for the Interaction of Ligands with Monoamine G Protein-coupled Receptors: Implications for Combinatorial Ligand Design. Quant. Struct.-Act. Relat. 1999, 18, 561-572.
6. Jacoby, E. A Novel Chemogenomics Knowledge-Based Ligand Design Strategy - Application to G Protein-Coupled Receptors. Quant. Struct.-Act. Relat. 2001, 20, 115-123.
7. Milligan, G.; Kellett, E.; Dacquet, C.; Dubreuil, V.; Jacoby, E. et al. S 14506: novel receptor coupling at 5-HT(1A) receptors. Neuropharmacology 2001, 40, 334-344.
8. Strnad, J.; Hadcock, J. R. Identification of a critical aspartate residue in transmembrane domain three necessary for the binding of somatostatin to the somatostatin receptor SSTR2. Biochem. Biophys. Res. Commun. 1995, 216, 913-921.
9. Mirzadegan, T.; Diehl, F.; Ebi, B.; Bhakta, S.; Polsky, I. et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J. Biol. Chem. 2000, 275, 25562-25571.
10. Moro, S.; Guo, D.; Camaioni, E.; Boyer, J. L.; Harden, T. K. et al. Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J. Med. Chem. 1998, 41, 1456-1466.
11. Roth, B. L.; Craigo, S. C.; Choudhary, M. S.; Uluer, A.; Monsma, F. J., Jr. et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 1994, 265, 1403-1410.
12. Vanhoenacker, P.; Haegeman, G.; Leysen, J. E. 5-HT7 receptors: current knowledge and future prospects. Trends Pharmacol. Sci. 2000, 21, 70-77.
13. Jovanovska, A.; Prosser, R. A. Translational and transcriptional inhibitors block serotonergic phase advances of the suprachiasmatic nucleus circadian pacemaker in vitro. J. Biol. Rhythms 2002, 17, 137-146.
14. Villalon, C. M.; Centurion, D.; Valdivia, L. F.; De Vries, P.; Saxena, P. R. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proc. West Pharmacol Soc. 2002, 45, 199-210.
15. ICM version 3; Molsoft LLC, San Diego, CA.
16. Abagyan, R.; Batalov, S.; Cardozo, T.; Totrov, M.; Webber, J. et al. Homology modeling with internal coordinate mechanics: deformation zone mapping and improvements of models via conformational search. Proteins 1997, Suppl, 29-37.
17. Cardozo, T.; Totrov, M.; Abagyan, R. Homology modeling by the ICM method. Proteins 1995, 23, 403-414.
18. Personal communication, Torsten Sejlitz.
19. Thompson, J. D.; Gibson, T. J.; Plewniak, F.; Jeanmougin, F.; Higgins, D. G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25, 4876-4882.
20. Fargin, A.; Raymond, J. R.; Lohse, M. J.; Kobilka, B. K.; Caron, M. G. et al. The genomic clone G-21 which resembles a beta-adernergic receptor sequence encodes the 5-HT1A receptor. Nature 1988, 335, 358-360.
21. Bard, J. A.; Zgombick, J.; Adham, N.; Vaysse, P.; Branchek, T. A. et al. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase. J. Biol. Chem. 1993, 268, 23422-23426.
22. Howe, K.; Bateman, A.; Durbin, R. QuickTree: building huge Neighbour-Joining trees of protein sequences. Bioinformatics 2002, 18, 1546-1547.
23. UNITY, version 4.3; Tripos Inc., 1699 South Hanley Rd, St. Louis, MO, 63144.
24. LEGION; Tripos Inc., 1699 South Hanley Rd, St. Louis, MO, 63144.
25. ChemEnlighten; Tripos Inc., 1699 South Hanley Rd, St. Louis, MO.
26. SIMCA-P+; Umetrics AB, Sweden.
27. Perrone, R.; Berardi, F.; Colabufo, N. A.; Lacivita, E.; Leopolde, M. et al. Synthesis and structure-affinity relationships of 1-[omega-(4-aryl-1- piperazinyl)alkyl]-1-aryl ketones as 5-HT(7) receptor ligands. J. Med. Chem. 2003, 46, 646-649.
28. Thomas, D. R.; Melotto, S.; Massagrande, M.; Cribble, A. D.; Jeffrey, P. et al. SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br. J. Pharmacol. 2003, 139, 705-714.
29. Hagan, J. J.; Price, G. W.; Jeffrey, P.; Deeks, N. J.; Stean, T. et al. Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br. J. Pharmacol. 2000, 130, 539-548.
30. Lovell, P. J.; Bromidge, S. M.; Dabbs, S.; Duckworth, D. M.; Forbes, I. T. et al. A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem. 2000, 43, 342-345.
31. Parikh, V.; Welch, W. M.; Schmidt, A. W. Discovery of a series of (4,5-dihydroimidazol-2-yl)-biphenylamine 5-HT7 agonists. Bioorg. Med. Chem. Lett. 2003, 13, 269-271.
32. Linnanen, T.; Brisander, M.; Unelius, L.; Rosqvist, S.; Nordvall, G. et al. Atropisomeric derivatives of 2′,6′-disubstituted (R)-11-phenylaporphine: selective serotonin 5-HT(7) receptor antagonists. J. Med. Chem. 2001, 44, 1337-1340.
33. Linnanen, T.; Brisander, M.; Mohell, N.; Johansson, A. M. Serotonergic and dopaminergic activities of rigidified (R)-aporphine derivatives. Bioorg. Med. Chem. Lett. 2001, 11, 367-370.
34. Kikuchi, C.; Ando, T.; Watanabe, T.; Nagaso, H.; Okuno, M. et al. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetranydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor. J. Med. Chem. 2002, 45, 2197-2206.
35. Kikuchi, C.; Suzuki, H.; Hiranuma, T.; Koyama, M. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability. Bioorg. Med. Chem. Lett. 2003, 13, 61-64.
36. Forbes, I. T.; Douglas, S.; Gribble, A. D.; Ife, R. J.; Lightfoot, A. P. et al. SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties. Bioorg. Med. Chem. Lett. 2002, 12, 3341-3344.
37. Lopez-Rodriguez, M. L.; Porras, E.; Benhamu, B.; Ramos, J. A.; Morcillo, M. J. et al. First pharmacophoric hypothesis for 5-HT7 antagonism. Bioorg. Med. Chem. Lett. 2000, 10, 1097-1100.
38. Glide; Schrodinger, 1500 SW First Avenue, Suite 1180, Portland, OR 97201.
39. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids. J. Am. Chem. Soc. 1996, 118, 11225-11236.
40. Vigers, G. P.; Rizzi, J. P. Multiple active site corrections for docking and virtual screening. J. Med. Chem. 2004, 47, 80-89.
41. Jones, G.; Willett, P.; Glen, R. C. A genetic algorithm for flexible molecular overlay and pharmacophore elucidation. J. Comput.-Aided Mol. Des. 1995, 9, 532-549.
42. Lopez-Rodriguez, M. L.; Porras, E.; Morcillo, M. J.; Benhamu, B.; Soto, L. J. et al. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives. J. Med. Chem. 2003, 46, 5638-5650.
43. Vermeulen, E. S.; Schmidt, A. W.; Sprouse, J. S.; Wikstrom, H. V.; Grol, C. J. Characterization of the 5-HT(7) receptor. Determination of the pharmacophore for 5-HT(7) receptor agonism and CoMFA-based modeling of the agonist binding site. J. Med. Chem. 2003, 46, 5365-5374.
44. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001, 46, 3-26.
45. Bondensgaard, K.; Ankersen, M.; Thogersen, H.; Hansen, B. S.; Wulff, B. S. et al. Recognition of privileged structures by G-protein coupled receptors. J. Med. Chem. 2004, 47, 888-899.
46. Ballesteros, J. A.; Shi, L.; Javitch, J. A. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. Mol. Pharmacol. 2001, 60, 1-19.
47. Cavasotto, C. N.; Orry, A. J.; Abagyan, R. A. Structure-based identification of binding sites, native ligands and potential inhibitors for G-protein coupled receptors. Proteins 2003, 51, 423-433.